Pulmatrix, Inc. (PULM)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Oct 23, 16:00
1.46
-0.02
(-1.35%)
After-Hours: 20:00
Pulmatrix Price to Book Value : 3.398 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.398 |
| October 22, 2026 | 3.260 |
| October 21, 2026 | 3.604 |
| October 20, 2026 | 3.283 |
| October 19, 2026 | 3.260 |
| October 16, 2026 | 3.122 |
| October 15, 2026 | 3.237 |
| October 14, 2026 | 3.145 |
| October 13, 2026 | 3.168 |
| October 12, 2026 | 3.283 |
| October 09, 2026 | 3.352 |
| October 08, 2026 | 3.506 |
| October 07, 2026 | 3.420 |
| October 06, 2026 | 3.283 |
| October 05, 2026 | 3.398 |
| October 02, 2026 | 3.604 |
| October 01, 2026 | 3.535 |
| September 30, 2026 | 3.489 |
| September 29, 2026 | 3.574 |
| September 28, 2026 | 3.65 |
| September 25, 2026 | 3.696 |
| September 24, 2026 | 3.834 |
| September 23, 2026 | 3.868 |
| September 22, 2026 | 3.902 |
| September 21, 2026 | 3.857 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.306 |
| September 17, 2026 | 3.289 |
| September 16, 2026 | 3.214 |
| September 15, 2026 | 3.317 |
| September 14, 2026 | 3.329 |
| September 11, 2026 | 3.237 |
| September 10, 2026 | 3.352 |
| September 09, 2026 | 3.398 |
| September 08, 2026 | 3.202 |
| September 04, 2026 | 3.191 |
| September 03, 2026 | 3.122 |
| September 02, 2026 | 3.374 |
| September 01, 2026 | 3.501 |
| August 31, 2026 | 3.374 |
| August 28, 2026 | 3.466 |
| August 27, 2026 | 3.489 |
| August 26, 2026 | 3.501 |
| August 25, 2026 | 3.673 |
| August 24, 2026 | 3.558 |
| August 21, 2026 | 3.432 |
| August 20, 2026 | 3.443 |
| August 19, 2026 | 3.489 |
| August 18, 2026 | 3.558 |
| August 17, 2026 | 3.581 |
| August 14, 2026 | 3.535 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| Price | 1.48 |
| Earnings Yield | -74.53% |
| Market Cap | 5.405M |